AB and AW are supported by the Wellcome Trust Strategic Award in Medical Mycology and Fungal Immunology (G097377). AS was funded by an MRC Clinical Research Fellowship (MR/K002708/1). AW is supported by the MRC Centre for Medical Mycology (MR/N006364/1) at the University of Aberdeen. DAJ is supported by a Wellcome Trust Seed Award (204566/Z/16/Z).Peer reviewedPublisher PD
Ibrutinib (Imbruvica®, also known as PCI-32765) is a first-in-class, irreversible small-molecule inh...
In lymphoid organs, nurse-like cells (NLCs) show properties of tumor-associated macrophages, playing...
The activation of the B cell receptor (BCR) is nowadays known to play a primary role in the etiopath...
Over recent years, the role of fungal pathogens within the respiratory microbiome has been increasin...
The Bruton tyrosine kinase (BTK) inhibitor ibrutinib is increasingly used in the treatment of chroni...
The Bruton tyrosine kinase (BTK) inhibitor ibrutinib is increasingly used in the treatment of chroni...
Infections represent a cause of morbidity and mortality in patients affected by chronic lymphocytic ...
Infections represent a cause of morbidity and mortality in patients affected by chronic lymphocytic ...
BTK inhibitors (BTKi) play a major role in the treatment of Chronic Lymphocytic Leukemia (CLL). Ibru...
The Bruton's tyrosine kinase (Btk) inhibitor ibrutinib has demonstrated promising efficacy in a...
Ibrutinib is a BTK/ITK inhibitor with efficacy for the treatment of various lymphoid cancers, includ...
Ibrutinib is a tyrosine kinase inhibitor used in the treatment of a variety of lymphoid malignancies...
BACKGROUND: Streptococcus pneumoniae is a major causative agent in community-acquired pneumonia and ...
Background and Purpose: There are no medications currently available to treat metabolic inflammation...
Background and Purpose: There are no medications currently available to treat metabolic inflammation...
Ibrutinib (Imbruvica®, also known as PCI-32765) is a first-in-class, irreversible small-molecule inh...
In lymphoid organs, nurse-like cells (NLCs) show properties of tumor-associated macrophages, playing...
The activation of the B cell receptor (BCR) is nowadays known to play a primary role in the etiopath...
Over recent years, the role of fungal pathogens within the respiratory microbiome has been increasin...
The Bruton tyrosine kinase (BTK) inhibitor ibrutinib is increasingly used in the treatment of chroni...
The Bruton tyrosine kinase (BTK) inhibitor ibrutinib is increasingly used in the treatment of chroni...
Infections represent a cause of morbidity and mortality in patients affected by chronic lymphocytic ...
Infections represent a cause of morbidity and mortality in patients affected by chronic lymphocytic ...
BTK inhibitors (BTKi) play a major role in the treatment of Chronic Lymphocytic Leukemia (CLL). Ibru...
The Bruton's tyrosine kinase (Btk) inhibitor ibrutinib has demonstrated promising efficacy in a...
Ibrutinib is a BTK/ITK inhibitor with efficacy for the treatment of various lymphoid cancers, includ...
Ibrutinib is a tyrosine kinase inhibitor used in the treatment of a variety of lymphoid malignancies...
BACKGROUND: Streptococcus pneumoniae is a major causative agent in community-acquired pneumonia and ...
Background and Purpose: There are no medications currently available to treat metabolic inflammation...
Background and Purpose: There are no medications currently available to treat metabolic inflammation...
Ibrutinib (Imbruvica®, also known as PCI-32765) is a first-in-class, irreversible small-molecule inh...
In lymphoid organs, nurse-like cells (NLCs) show properties of tumor-associated macrophages, playing...
The activation of the B cell receptor (BCR) is nowadays known to play a primary role in the etiopath...